CardioLogs ECG Analysis Platform vs Cleerly ISCHEMIA

CardioLogs offers a pure cloud-based SaaS model with broad multi-device compatibility (Holter, smartwatches, ECG patches) and easy EHR integration, allowing clinicians to work from anywhere with minimal setup. While Cleerly provides efficient workflows and interactive reports, its reliance on a 'Cleerly Proxy' for data transfer might introduce more IT overhead compared to CardioLogs' straightforward SaaS deployment.

Cleerly ISCHEMIA provides a more comprehensive and personalized diagnostic insight into coronary artery disease by non-invasively assessing ischemia likelihood, quantifying plaque characteristics, and estimating FFR from CCTA scans. Multiple clinical trials have validated its high diagnostic accuracy and impact on clinical decision-making, including reducing the need for further invasive testing. While CardioLogs offers valuable arrhythmia detection, Cleerly's detailed, non-invasive assessment of CAD pathology represents a deeper level of clinical insight for treatment planning.

CardioLogs offers a more transparent and predictable 'pay per ECG' pricing model, which allows for clear budgeting based on usage. Cleerly's pricing is less transparent, varying by provider, and while it has CPT codes for billing, insurance coverage can be inconsistent, making the overall cost to the patient or institution less predictable.

Both tools demonstrate strong enterprise readiness with FDA clearance, HIPAA compliance, and BAA availability. CardioLogs leverages a pure cloud-based SaaS model with ISO/IEC 27001 certification and EHR integration. Cleerly, while using a web-based platform with a proxy for data transfer, also offers robust IT integration support and API integration with systems like PowerScribe. Both are well-equipped for secure and compliant deployment in healthcare enterprises.

Cleerly ISCHEMIA demonstrates greater innovation by providing non-invasive fractional flow reserve (FFR) estimation and detailed coronary plaque characterization from CCTA scans, offering a deeper and more personalized understanding of coronary artery disease without invasive procedures. While CardioLogs was an early FDA-cleared AI for ECG analysis and supports multi-device compatibility, Cleerly's approach to non-invasive ischemia detection and plaque analysis pushes the boundaries of cardiac diagnostics more significantly.

Both companies provide clear channels for support and documentation. CardioLogs, as a Philips solution, offers a support center, product manuals, and phone support. Cleerly provides dedicated client support via an online form and specifies business hours for assistance. Neither explicitly details the breadth or depth of their documentation or the specifics of their support SLAs, making it difficult to distinguish a clear winner.